A Comparative Analysis Between Survivors and Nonsurvivors with Antibody Mediated Cardiac Allograft Rejection

Journal of Surgical Research

Volumn 142, Issue 2, 2007, Pages 233-238

  Gonzalez Stawinski, Gonzalo V ^a   Cook, Daniel J ^a   Chui, Jorge ^a   Gupta, Sandeep ^a   Navia, Jose L ^a   Hoercher, Katherine ^a   Taylor, David O ^a   Yamani, Mohamed H ^a   Starling, Randall C ^a   Smedira, Nicholas G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

antibody; heart transplantation; outcomes; rejection

Indexed keywords

ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN G; RITUXIMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CHILD; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HEART HEMODYNAMICS; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SURVIVAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIBODIES; CAUSE OF DEATH; CHILD; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548670735     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.04.023     Document Type: Article

References (24)

1. Michaels P.J., Espejo M.L., Kobashigawa J., et al. Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 22 (2003) 58
2. Olsen S.L., Wagoner L.E., Hammond E.H., et al. Vascular rejection in heart transplantation: Clinical correlation, treatment options, and future considerations. J Heart Lung Transplant 12 (1993) S135
3. Behr T.M., Feucht H.E., Richter K., et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 18 (1999) 904
4. Herskowitz A., Soule L.M., Ueda K., et al. Arteriolar vasculitis on endomyocardial biopsy: A histologic predictor of poor outcome in cyclosporine-treated heart transplant recipients. J Heart Transplant 6 (1987) 127
5. Hammond E.H., Yowell R.L., Nunoda S., et al. Vascular (humoral) rejection in heart transplantation: Pathologic observations and clinical implications. J Heart Transplant 8 (1989) 430
6. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710
7. Reed E.F., Demetris A.J., Hammond E., et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 25 (2006) 153
8. Cook D.J., Klingman L.L., Koo A.P., et al. Quantitative flow cytometry cross-matching for precise measurement of donor-specific alloreactivity. Transplant Proc 26 (1994) 2866
9. Hammond E.H., Hansen J.K., Spencer L.S., et al. Immunofluorescence of endomyocardial biopsy specimens: Methods and interpretation. J Heart Lung Transplant 12 (1993) S113
10. Taylor D.O., Yowell R.L., Kfoury A.G., et al. Allograft coronary artery disease: Clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection. J Heart Lung Transplant 19 (2000) 518
11. Miller L.W., Wesp A., Jennison S.H., et al. Vascular rejection in heart transplant recipients. J Heart Lung Transplant 12 (1993) S147
12. Gupta S., Cook D.J., Sharma M., et al. Virtual Cross-match allows the expansion of effective donor pool for HLA sensitized patients. J Heart Lung Transplant 25 (2006) 140
13. Barr M.L., Cohen D.J., Benvenisty A.I., et al. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. Transplant Proc 25 (1993) 262
14. Girnita A.L., McCurry K.R., Iacono A.T., et al. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant 23 (2004) 1135
15. Hammond E.H., Ensley R.D., Yowell R.L., et al. Vascular rejection of human cardiac allografts and the role of humoral immunity in chronic allograft rejection. Transplant Proc 23 2 Suppl 2 (1991) 26
16. Rahimi S., Qian Z., Layton J., et al. Noncomplement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant 4 (2004) 326
17. Reed E., Ho E., Cohen D.J., et al. Anti-idiotypic antibodies specific for HLA in heart and kidney allograft recipients. Immunol Res 12 (1993) 1
18. Hammond E.H., Yowell R.L., Price G.D., et al. Vascular rejection and its relationship to allograft coronary artery disease. J Heart Lung Transplant 11 (1992) S111
19. Costanzo-Nordin M.R., Heroux A.L., Radvany R., et al. Role of humoral immunity in acute cardiac allograft dysfunction. J Heart Lung Transplant 12 (1993) S143
20. Lones M.A., Czer L.S., Trento A., et al. Clinical-pathologic features of humoral rejection in cardiac allografts: A study in 81 consecutive patients. J Heart Lung Transplant 14 (1995) 151
21. Scoazec J.Y., Delautier D., Moreau A., et al. Expression of complement-regulatory proteins in normal and UW-preserved human liver. Gastroenterology 107 (1994) 505
22. Yamada K., Miwa T., Liu J., et al. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 172 (2004) 3869
23. Chen R.H., Naficy S., Logan J.S., et al. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation 6 (1999) 194
24. McCurry K.R., Kooyman D.L., Alvarado C.G., et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1 (1995) 423